AI assistant
Berkeley Group Holdings PLC — Director's Dealing 2019
Jul 12, 2019
4688_dirs_2019-07-12_e19df9b6-5765-4039-bad7-27449b8ef715.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 4407F
Berkeley Group Holdings (The) PLC
12 July 2019
12 July 2019
The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation
1.
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Karl Whiteman
2.
Reason for the notification
a)
Position / status
Divisional Executive Director
b)
Initial notification / amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
The Berkeley Group Holdings plc
b)
LEI
2138009OQSSLVVHQAL78
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification Code
Ordinary Shares of 5p each
ISIN: GB00B02L3W35
b)
Nature of the transaction(s)
Sale of Ordinary Shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £38.17291 | 31,500 |
d)
Aggregated information
- Aggregated volume
- Price
31,500
£38.17291
e)
Date of the transaction
2019-07-12
f)
Place of the transaction
London Stock Exchange, Main Market (XLON) (13,177 shares)
CHI-X (CHIX) (8,173 shares)
Turquoise (TRQX) (3,099 shares)
Aquis (AQXE) (2,014 shares)
BATS Chi-X Europe (BATE) (1,774 shares)
UBS (MTF) (1,766 shares)
BATS Global markets (BATS) (1,497 shares)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHSFAFIEFUSELW